A 72-year-old White male complained of memory loss, trouble recalling names and events, and a regular-duty deterioration. Hypertension, type 2 diabetes, and hyperlipidemia characterized the patient's history. He never drank or used drugs. His mother had Alzheimer's, and his father had a stroke. The patient's physical examination was unremarkable except for a 20-out-of-30 Mini-Mental State Examination (MMSE) score, suggesting mild cognitive impairment. Rivastigmine 1.5 mg twice a day was started, with a four-week escalation to 6 mg twice daily. He was given a cholinesterase inhibitor and memantine to slow cognitive impairment. Treatment efficacy and side effects were extensively examined.